Abstract
The human parvovirus B19 (B19) was discovered in 1975. Parvovirus B19 is the only known human pathogenic parvovirus. Unlike many virus infections, the disease manifestation of infection with parvovirus B19 varies widely with the immunologic and hematologic status of the host. In individuals with underlying hemolytic disorders, B19 is the primary cause of aplastic crisis. In immunocompromised patients, persistent B19 viremia may develop that manifests as pure red cell aplasia and chronic anemia, and in the fetus, where the immune response is immature infection, it may lead to fetal death in utero or hydrops fetalis. The major disease manifestation in normal, immunocompetent individuals is erythema infectiosum (EI), also called fifth disease or “slapped-cheek” disease. Generally this is an innocuous rash disease of childhood, but in adults it may also be associated with an acute symmetrical polyarthropathy, which can mimic acute rheumatoid arthritis.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
Adler, S. P., Manganello, A. M., Koch, W. C., Hempfling, S. H., And Best, A. M., Risk of human parvovirus B19 infections among school and hospital employees during endemic periods, J. Infect. Dis. 168: 361–368 (1993).
Agbandje, M., Kajigaya, S., Mckenna, R., Young, N. S., And Rossmann, M. G., The structure of human parvovirus B19 at 8;Si resolution, Virology 203: 106–115 (1994).
Ager, A. E., Chin, T. D. J., And Poland, J. D., Epidemic erythema infectiosum, N. Engl. J. Med. 275: 1326–1331 (1966).
Anderson, L. J., Role of parvovirus B19 in human disease, Pediatr. Infect. Dis. J. 6: 711–178 (1987).
Anderson, L. J., Tsou, C., Parker, R. A., Chorba, T. L., Wulff, H., Tattersall, P., And Mortimer, P. P., Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay, J. Clin. Microbiol. 24: 522–526 (1986).
Anderson, M. J., And Cohen, B. J., Human parvovirus B19 infections in United Kingdom 1984–86 [letter], Lancet 1: 738–739 (1987).
Anderson, M. J., Davis, L. R., Hodgson, J., Jones, S. E., Murtaza, L., Pattison, J. R., Stroud, C. E., And White, J. M., Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period, J. Clin. Pathol. 35: 744–749 (1982).
Anderson, M. J., Higgins, P. G., Davis, L. R., Willman, J. S., Jones, S. E., Kidd, I. M., Pattison, J. R., And Tyrrell, D. A., Experimental parvoviral infection in humans, J. Infect. Dis. 152: 257–265 (1985).
Anderson, M. J., Jones, S. E., Fisher-Hock, S. P., Lewis, E., Hall, S. M., Bartlett, C. L. R., Cohen, B. J., Mortimer, P. R, And Pereira, M. S., Human parvovirus, the cause of erythema infectiosum (fifth disease)? [letter], Lancet 1: 1378 (1983).
Anderson, M. J., Jones, S. E., And Minson, A. C., Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral Dna, J. Med. ViroL 15: 163–172 (1985).
Anderson, M. J., Lewis, E., Kidd, I. M., Hall, S. M, And Cohen, B. J., An outbreak of erythema infectiosum associated with human parvovirus infection, J. Hyg. (Lund.) 93: 85–93 (1984).
AzzI, A., Ciappi, S., Zakvrzewska, K., Morfini, M., Marian, G., And Mannucci, R M., Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor Viii concentrates, Am. J. HematoL 39: 228–230 (1992).
Balfour, H. H., Erythema infectiosum (fifth disease). Clinical review and description of 91 cases seen in an epidemic, Clin. Pediatr. 8: 721–727 (1969).
Bansal, G. R, Hatfield, J., Dunn, F. E., Warrener, R, Young, J. F., Top, F. H., JR., Collett, M. S., Anderson, S., Rosenfeld, S., Kajigaya, S., And Young, N. S., Immunogenicity studies of recombinant human parvovirus B19 proteins, in: Vaccines 92 (F. Brown, R. M. Chanock, H. S. Ginsberg, And R. A. Lerner, Eds.), PP. 315–319, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1992.
Bartolomei Corsi, O., Azzi, A., Morfini, M., Fanci, R., And Rossi Ferrini, R, Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates, J. Med. ViroL 25: 165–170 (1988).
Beard, C., ST. Amand, J., And Astell, C. R., Transient expression of B19 parvovirus gene products in Cos-7 cells transfected with B19–SV40 hybrid vectors, Virology 172: 659–664 (1989).
Bell, L. M., Naides, S. J., Stoffman, R, Hodinka, R. L., And Plotkin, S. A., Human parvovirus B19 infection among hospital staff members after contact with infected patients, N. Engl. J. Med. 321: 485–491 (1989).
Blundell, M. C., Beard, C., And Astell, C. R., In vitro identification of a B19 parvovirus promoter, Virology 157: 534–538 (1987).
Brown, C. S., Van Lent, J. W, Vlak, J. M., And Spaan, W. J., Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins, J. ViroL 65: 2702–2706 (1991).
Brown, K. E., Anderson, S. M., And Young, N. S., Erythrocyte P antigen: Cellular receptor for B19 parvovirus, Science 262: 114–117 (1993).
Brown, K. E., Green, S. W., Antunez DE Mayolo, J., Bellanti, J. A., Smith, S. D., Smith, T. J., And Young, N. S., Congenital anaemia after transplacental B19 parvovirus infection, Lancet 343: 895–896 (1994).
Brown, K. E., Hibbs, J. R., Gallinella, G., Anderson, S. M., Lehman, E. D., Mccarthy, R, And Young, N. S., Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen), N. Engl. J. Med. 330: 1192–1196 (1994).
Brown, K. E., Mori, J., Cohen, B. J., And Field, A. M., In vitro propagation of parvovirus B19 in primary foetal liver culture, J. Gen. Virol. 72: 741–745 (1991).
Carstensen, H, Ornvold, K., And Cohen, B. J., Human parvovirus B19 infection associated with prolonged erythroblastopenia in a leukemic child, Pediatr. Infect. Dis. J. 8: 56 (1989).
Cheinisse, L., Une cinquième maladie éruptive: Le mégalérythème épidémique, Sem. Med. 25: 205–207 (1905).
Chorba, T., Coccia, P., Holman, R. C., Tattersall, P, Anderson, L. J., Sudman, J., Young, N. S., Kurczynski, E., Saarinen, U. M., Moir, R., Lawrence, D. N., Jason, J. M., And Evatt, B., The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease), J. Infect. Dis. 154: 383–393 (1986).
Clewley, J. P., Detection of human parvovirus using a molecularly cloned probe, J. Med. Virol. 15: 173–181 (1985).
Clewley, J. P., Cohen, B. J., And Field, A. M., Detection of parvovirus B19 Dna, antigen, and particles in the human fetus, J. Med. Virol. 23: 367–376 (1987).
Cohen, B. J., Human parvovirus B19 infection in Kawasaki disease [letter], Lancet 344: 59 (1994).
Cohen, B. J., And Brown, K. E., Laboratory infection with human parvovirus B19 [letter], J. Infect. 24: 113–114 (1992).
Cohen, B. J., And Buckley, M. M., The prevalence of antibody to human parvovirus B19 in England and Wales, J. Med. Microbiol. 25: 151–153 (1988).
Cohen, B. J., Field, A. M., Gudnadottir, S., Beard, S., And Barbara, J. A., Blood donor screening for parvovirus B19, J. Viral. Methods. 30: 233–238 (1990).
Cohen, B. J., Mortimer, P. P., And Pereira, M. S., Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (Splv), J. Hyg. (Load.) 91: 113–130 (1983).
Conrad, M. E., Studdard, H., And Anderson, L. J., Aplastic crisis in sickle cell disorders: Bone marrow necrosis and human parvovirus infection, Am. J. Med. Sci. 295: 212–215 (1988).
Corman, L. C., And Dolson, D. J., Polyarteritis nodosa and parvovirus B19 infection [letter], Lancet 339: 491 (1992).
Cossart, Y. E., Field, A. M., Cant, B., And Widdows, D., Parvovirus-like particles in human sera, Lancet 1: 72–73 (1975).
Courouce, A. M., Ferchal, F., Morinet, F., Muller, A., Drouet, J., Soulier, J. P., And Perol, Y., Human parvovirus infections in France [letter], Lancet 1: 160 (1984).
DE Frettas, R. B., Wong, D., Boswell, F., DE Miranda, M. F., Linhares, A. C., Shirley, J., And Desselberger, U., Preva-
lence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil, J. Med. Virol. 32: 203–208 (1990).
Delannoy, D., Balquet, M. H., And Savinel, P., [Vasculitis with mixed cryoglobulin in human parvovirus B19 infection (letter)], Presse Med. 22: 175 (1993).
Denning, D. W., Amos, A., Rudge, P., And Cohen, B. J., Neuralgic amyotrophy due to parvovirus infection [letter], J. Neurol. Neurosurg. Psychiatry 50: 641–642 (1987).
Erdman, D. D., Usher, M. J., Tsou, C., Caul, E. O., Gary, G. W., Kajigaya, S., Young, N. S., And Anderson, L. J., Human parvovirus B19 specific IgG, IgA, and IgM antibodies and Dna in serum specimens from persons with erythema infectiosum, J. Med. Viral. 35: 110–115 (1991).
Evans, J. P., Rossiter, M. A., Kumaran, T. O., Marsh, G. W., And Mortimer, P. P., Human parvovirus aplasia: Case due to cross-infection in a ward, Br. Med. J. 288: 681 (1984).
Faden, H., Gary, G. W., JR., And Korman, M., Numbness and tingling of fingers associated with parvovirus B19 infection [letter], J. Infect. Dis. 161: 354–355 (1990).
Field, A. M., Cohen, B. J., Brown, K. E., Mori, J., Clewley, J. P., Nascimento, J. P., And Hallam, N. F., Detection of B19 parvovirus in human fetal tissues by electron microscopy, J. Med. Virol. 35: 85–95 (1991).
Field, A. M., Cohen, B. J., Brown, K. E., Mori, J., Clewley, J. P., Nascimento, J. P., And Hallam, N. F., Detection of B19 parvovirus in human fetal tissues by electron microscopy, J. Med. Virol. 35: 85–95 (1991).
Finkel, T. H., Torok, T. J., Ferguson, P. J., Durigon, E. L., Zaki, S. R., Leung, D. Y., Harbeck, R. J., Gelfand, E. W., Saulsbury, F. T., And Hollister, J. R., Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet 343: 1255–1258 (1994).
Foreman, N. K., Oakhill, A., And Caul, E. O., Parvovirusassociated thrombocytopenic purpura [letter], Lancet 2: 14261427 (1988).
Frickhofen, N., Abkowitz, J. L., Safford, M., Berry, J. M., Antunez-DE-Mayolo, J., Astrow, A., Cohen, R., Halperin, I., King, L., Mintzer, D., Cohen, B., And Young, N. S., Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (Hiv-1): A treatable cause of anemia in Aids, Ann. Intern. Med. 113: 926–933 (1990).
Frickhofen, N., Arnold, R., Hertenstein, B., Wiesneth, M., And Young, N. S., Parvovirus B19 infection and bone marrow transplantation, Ann. Hematol. 64:Al21-Al24 (1992).
Frickhofen, N., And Young, N. S., Persistent parvovirus B19 infections in humans, Microb. Pathog. 7: 319–327 (1989).
Fridell, E., Trojnar, J., And Wahren, B., A new peptide for human parvovirus B19 antibody detection, Scand. J. Infect. Dis. 21: 597–603 (1989).
Gaches, F., Loustaud, V., Vidal, E., Delaire, L., Gutardschmid, J. B., Lavoine, E., Negrier, P., And Liozon, F., [Periarteritis nodosa and parvovirus B19 infection], Rev. Med. Interne. 14: 323–325 (1993).
Gillespie, S. M., Cart-Ter, M. L., Asch, S., Rokos, J. B., Gary, G. W., Tsou, C. J., Hall, D. B., Anderson, L. J., And Hurwitz, E. S., Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum, J.A.M.A. 263: 2061–2065 (1990).
Godeau, B., Galacteros, F., Schaeffer, A., Morinet, F., Bachir, D., Rosa, J., And Portos, J. L., Aplastic crisis due to extensive bone marrow necrosis and human parvovirus infection in sickle cell disease [letter], Am. J. Med. 91: 557–558 (1991).
Hamon, M. D., Newland, A. C., And Anderson, M. J., Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia [letter], J. Clin. Pathol. 41: 1242 (1988).
Jones, P. H., Pickett, L. C., Anderson, M. J., And Pas Vol, G., Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria, J. Trop. Med. Hyg. 93: 67–70 (1990).
Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., Shimada, T., And Young, N. S., Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions, Proc. Natl. Acad. Sci. Usa 88: 4646–4650 (1991).
Kajigaya, S., Shimada, T., Fujita, S., And Young, N. S., Agenetically engineered cell line that produces empty capsids of B19 (human) parvovirus, Proc. Natl. Acad. Sci. Usa 86: 7601–7605 (1989).
Kinney, J. S., Anderson, L. J., Farrar, J., Strikas, R. A., Kumar, M. L., Kliegman, R. M., Sever, J. L., Hurwitz, E. S., And Sikes, R. K., Risk of adverse outcomes of pregnancy after human parvovirus B19 infection, J. Infect. Dis. 157: 663–667 (1988).
Knisely, A. S., O’Shea, P. A., Anderson, L. J., And Gary, G. W., JR., Parvovirus B19 infection, myocarditis, and death in a 3-year-old boy (Abstract), Pediatr Pathol. 8: 665 (1988).
Kocu, W. C., And Adler, S. P., Human parvovirus B19 infections in women of childbearing age and within families, Pediatr. Infect. Dis. J. 8: 83–87 (1989).
KozIol, D. E., Kurtzman, G., Ayub, J., Young, N. S., And Henderson, D. K., Nosocomial human parvovirus B19 infection: Lack of transmission from a chronically infected patient to hospital staff, Infect. Control. Hosp. Epidemiol. 13: 343–348 (1992).
Kurtzman, G., Frickhofen, N., Kimball, J., Jenkins, D. W., Nienhuis, A. W., And Young, N. S., Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy [see comments], N. Engl. J. Med. 321: 519–523 (1989).
Kurtzman, G. J., Cohen, B., Meyers, P., Amunullah, A., And Young, N. S., Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia, Lancet 2: 1159–1162 (1988).
Kurtzman, G. J., Cohen, B. J., Field, A. M., Oseas, R., Blaese, R. M., And Young, N. S., Immune response to B19 parvovirus and an antibody defect in persistent viral infection, J. Clin. Invest. 84: 1114–1123 (1989).
Lauer, B. A., Maccormack, J. N., And Wilfert, C., Erythema infectiosum: An elementary school outbreak, Am. J. Dis. Child. 130: 252–254 (1976).
Lefrere, J. J., Comma, A. M., Muller, J. Y., Clark, M., And Soulier, J. P., Human parvovirus and purpura [letter], Lancet 2: 730 (1985).
Leruez-Ville, M., Lauge, A., Morinet, F., Guillevin, L., And Deny, P., Polyarteritis nodosa and parvovirus B19 [letter], Lancet 344: 263–264 (1994).
Levine, P., Celano, M. J., And Falkowski, E, The specificity of the autoantibody in paroxysmal cold haemoglobinuria (Pch), Transfusion 3: 278–280 (1963).
LI Loong, T. C., Coyle, P. V., Anderson, M. J., Allen, G. E., And Connolly, J. H., Human serum parvovirus associated vasculitis, Postgrad. Med. J. 62: 493–494 (1986).
LIu, M., Green, S. W., Shimada, T., And Young, N. S., A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus, J. Virol. 66: 4686–4692 (1992).
Lortholary, O., Eliaszewicz, M., Dupont, B., And Courouce, A. M., Parvovirus B19 infection during acute Plasmodium falciparum malaria [letter], Eur. J. Haematol. 49: 219 (1992).
Lopez DE Turiso, J. A., Cortes, E., Martinez, C., Ruiz DE YBÄNez, R., Simarro, I., Vela, C., And Casal, I., Recombinant vaccine for canine parvovirus in dogs, J. Virol. 66: 2748–2753 (1992).
Luzzi, G. A., Kurtz, J. B., And Chapel, H., Human parvovirus arthropathy and rheumatoid factor [letter], Lancet 1: 1218 (1985).
Lyon, D. J., Chapman, C. S., Martin, C., Brown, K. E., Clewley, J. P., Flower, A. J., And Mitchell, V. E., Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate [letter], Lancet 1: 1085 (1989).
McLellan, N. J., And Rutcer, N., Hereditary spherocytosis in sisters unmasked by parvovirus infection, Postgrad. Med. J. 63: 49–50 (1987).
McOmish, F., Yap, P. L., Jordan, A., Hart, H., Cohen, B. J., And Simmonds, P., Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction, J. Clin. Microbiol. 31: 323–328 (1993).
Morens, D. M., Fifth disease: Still hazy after all these years, J.A.M.A. 248: 553–554 (1982).
Morens, D. M., Fifth disease: Still hazy after all these years, J.A.M.A. 248: 553–554 (1982).
Morey, A. L., Ferguson, D. J., And Fleming, K. A., Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis, J. Pathol. 169: 213–220 (1993).
Morey, A. L., Keeling, J. W., Porter, H. J., And Fleming, K. A., Clinical and histopathological features of parvovirus B19 infection in the human fetus, Be J. Obstet. Gynaecol. 99: 566–574 (1992).
Mori, J., Beattie, P., Melton, D. W., Cohen, B. J., And Clewley, J. P., Structure and mapping of the Dna of human parvovirus B19, J. Gen. Virol. 68: 2797–2806 (1987).
MoRinet, E, D’Auriol, L., Tratschin, J. D., And Galibert, E, Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: Recognition by IgM and IgG antibodies in human sera, J. Gen. Virol. 70: 3091–3097 (1989).
Morinet, E, Tratschin, J. D., Perol, Y., And Siegl, G., Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Brief report, Arch. Virol. 90; 165–172 (1986).
Naides, S. J., And Field, E. H., Transient rheumatoid factor positivity in acute human parvovirus B19 infection, Arch. Intern. Med. 148: 2587–2589 (1988).
Naides, S. J., And Weiner, C. R, Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection, Prenat. Diagn. 9: 105–114 (1989).
Nascimento, J. R, Buckley, M. M., Brown, K. E., And Cohen, B. J., The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil, Rev. Inst. Med. Trop. Sao Paulo 32: 41–45 (1990).
Neild, G., Anderson, M., Hawes, S., And Colvin, B. T., Parvovirus infection after renal transplant [letter], Lancet 2: 1226–1227 (1986).
Nigro, G., Zerbini, M., Krzysztofiak, A., Gentilomi, G., Porcaro, M. A., Mango, T., And Musiani, M., Active or recent parvovirus B19 infection in children with Kawasaki disease, Lancet 343: 1260–1261 (1994).
Nlrlsu, H., Takatsu, H., Miura, I., Chubachi, A., ITo, T., Hirokawa, M., Endo, Y., Miura, A., Fukuda, M., And Sasaki, T., [Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation], Rinsho Ketsueki. 31: 1566–1571 (1990).
Nunoue, T., Okochi, K., Mortimer, P. R, And Cohen, B. J., Human parvovirus (B19) and erythema infectiosum, J. Pediatr. 107: 38–40 (1985).
Okabe, N., Koboyashi, S., Tatsuzawa, O., And Mortimer, R R, Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease), Arch. Dis. Child. 59: 1016–1019 (1984).
Owren, P. A., Congenital hemolytic jaundice: The pathogenesis of the “hemolytic crisis,” Blood 3: 231–248 (1948).
Ozawa, K., Kurtzman, G., And YouNG, N., Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro, Blood 70: 384–391 (1987).
Patou, G., Pillay, D., Myint, S., And Pattison, J., Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19, J. Clin. Microbiol. 31: 540–546 (1993).
Pattison, J. R., Jones, S. E., Hodgson, J., Davis, L. R., White, J. M., Stroud, C. E., And Murtaza, L., Parvovirus infections
and hypoplastic crisis in sickle-cell anaemia, Lancet 1: 664–665 (1981).
Pellas, F., Olivares, J. E, Zandotti, C., And Delarque, A., Neuralgic amyotrophy after parvovirus B19 infection [letter], Lancet 342: 503–504 (1993).
Pillay, D., Patou, G., Hurt, S., Kibbler, C. C., And Griffiths, P. D., Parvovirus B19 outbreak in a children’s ward, Lancet 339: 107–109 (1992).
Plummer, F. A., Hammond, G. W., Forward, K., Sekla, L., Thompson, L. M., Jones, S. E., Kidd, I. M., And Anderson, M. J., An erythema infectiosum-like illness caused by human parvovirus infection, N. Engl. J. Med. 313: 74–79 (1985).
Pont, J., Puchhammer-ST:Ockl, E., Chott, A., Popowkraupp, T., Kienzer, H., Postner, G., And Honetz, N., Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection, Br. J. Haematol. 80: 160–165 (1992).
Porter, H. J., Heryet, A., Quantrill, A. M., And Fleming, K. A., Combined non-isotopic in situ hybridisation and immunohistochemistry on routine paraffin wax embedded tissue: Identification of cell type infected by human parvovirus and demonstration of cytomegalovirus Dna and antigen in renal infection, J. Clin. Pathol. 43: 129–132 (1990).
Porter, H. J., Khong, T. Y., Evans, M. F., Chan, V. T., And Fleming, K. A., Parvovirus as a cause of hydrops fetalis: Detection by in situ Dna hybridisation, J. Clin. Pathol. 41: 381–383 (1988).
Porter, H. J., Quantrill, A. M., And Fleming, K. A., B19 parvovirus infection of myocardial cells [letter], Lancet 1: 535–536 (1988).
Potter, C. G., Potter, A. C., Hatton, C. S., Chapel, H. M., Anderson, M. J., Pattison, J. R., Tyrrell, D. A., Higgins, P. G., Willman, J. S., Parry, H. F., And Cotes, P. M., Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19), J. Clin. Invest. 79: 1486–1492 (1987).
Public Health Laboratory Service Working Party ON Fifth Disease, Prospective study of human parvovirus (B19) infection in pregnancy, Br. Med. J. 300: 1166–1170 (1990).
Rosenfeld, S. J., Yoshimoto, K., Kajigaya, S., Anderson, S., Young, N. S., Field, A., Warrener, P., Bansal, G., And Collett, M. S., Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface, J. Clin. Invest. 89: 2023–2029 (1992).
Rosenfeld, S. J., Young, N. S., Alling, D., Ayub, J., And Saxinger, C., Subunit interaction in B19 parvovirus empty capsids, Arch. Virol. 136: 9–18 (1994).
Rouger, P., Gane, P, And Salmon, C., Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies, Rev. Fr. Transfus. Immunohematol 30: 699–708 (1987).
Saarinen, U. M., Chorba, T. L., Tattersall, P., Young, N. S., Anderson, L. J., Palmer, E., And Coccia, P. E, Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia, Blood 67: 1411–1417 (1986).
Saint-Martin, J., Choulot, J. J., Bonnaud, E., And Morinet, E, Myocarditis caused by parvovirus [letter: comment], J. Pediatr. 116: 1007–1008 (1990).
Saliki, J. T., Mizak, B., Flore, H. E, Gettig, R. R., Burand, J. P., Carmichael, L. E., Wood, H. A., And Parrish, C. R., Canine parvovirus empty capsids produced by expression in a baculovirus vector: Use in analysis of viral properties and immunization of dogs, J. Gen. Virol. 73: 369–374 (1992).
Salimans, M. M., Van DE, R. I., Raap, A. K., And Van Elsacker-Niele, A M, Detection of parvovirus B19 Dna in fetal tissues by in situ hybridisation and polymerase chain reaction, J. Clin. Pathol. 42: 525–530 (1989).
Schwarz, T. E, Bruns, R., Schroder, C., Wiersbitzky, S., And Roggendorf, M., Human parvovirus B19 infection associated with vascular purpura and vasculitis [letter], Infection 17: 170–171 (1989).
Schwarz, T. F., Gurtler, L. G., Zoulek, G., Deinhardt, E, And Roggendorf, M., Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands, Int. J. Med. Microbiol. 271: 231–2, 36 (1989).
Serjeant, G. R., Serjeant, B. E., Thomas, P. E., Anderson, M. J., Patou, G., And Pattison, J. R., Human parvovirus infection in homozygous sickle cell disease, Lancet 341: 1237–1240 (1993).
Serjeant, G. R., Topley, J. M., Mason, K., Serjeant, B. E., Pattison, J. R., Jones, S. E., And Mohamed, R., Outbreak of aplastic crisis in sickle cell anaemia associated with parvoviruslike agent, Lancet 2: 595–597 (1981).
Siegl, G., Bates, R. C., Berns, K. I., Carter, B. J., Kelly, D. C., Kurstak, E., And Tattersall, P., Characteristics and taxonomy of Parvoviridae, Intervirology 23: 61–73 (1985).
Sisk, W. P, And Berman, M. L., Expression of human parvovirus B19 structural protein in E. coli and detection of antiviral antibodies in human serum, Bio/Technology 5: 1077–1080 (1987).
Smith, M. A., Shah, N. R., Lobel, J. S., Cera, P. J., Gary, G. W., And Anderson, L. J., Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy, Clin. Pediatr. 27: 383–386 (1988).
Sorensen, S. F., [Acute vasculitis and arthritis caused by parvovirus Bl9 infection], Ugeskr. Laeger 154: 2032–2033 (1992).
Takahashi, M., Koike, T., Moriyama, Y., And Shibata, A., Neutralizing activity of immunoglobulin preparation against erythropoietic suppression of human parvovirus [letter], Am. J. Hematol. 37: 68 (1991).
Takahashi, T., Ozawa, K., Takahashi, K., Asano, S., And Takaku, E, Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation, Blood 75: 603–610 (1990).
Umene, K., And Nunoue, T., The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: A correlation between genome type and prevalence, J. Gen. Virol. 71: 983–986 (1990).
Umene, K., And Nunoue, T., Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or five base pairs and partial nucleotide sequencing: Use of sequence variability in virus classification, J. Gen. Virol. 72: 1997–2001 (1991).
Van Horn, D. K., Mortimer, P. P., Young, N., And Hanson, G. R., Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia, Am. J. Pediatr. Hematol. Oncol. 8: 235–239 (1986).
Walsh, K. J., Armstrong, R. D., And Turner, A. M., Brachial plexus neuropathy associated with human parvovirus infection, Br. Med. J. 296: 896 (1988).
Warsof, S. L., Nicolaides, K. H., And Rodeck, C., Immune and non-immune hydrops, Clin. Obstet. Gynecol. 29: 533–542 (1986).
Weiland, H. T., Vermey-Keers, C., Salimans, M. M., Fleuren, G. J., Verwey, R. A., And Anderson, M. J., Parvovirus B19 associated with fetal abnormality [letter], Lancet 1: 682–683 (1987).
White, D. G., Woolf, A. D., Mortimer, P. P., Cohen, B. J., Blake, D. R., And Bacon, P. A., Human parvovirus arthropathy, Lancet 1: 419–421 (1985).
Wiersbitzky, S., Schwarz, T. F., Bruns, R., JÄGer, G., BrrrNer, S., Weidemann, H., Deinhardt, F., HottentrÄGer, B., Abel, E., Ladstatter, L., Frick, G., And Roggendorf, M., Seroprevalence of human parvovirus B19 antibodies (Sticker’s disease/erythema infectiosum) in the Drg population], Kinderarztl. Prax. 58: 185–189 (1990).
Williams, M. D., Cohen, B. J., Beddall, A. C., Pasi, K. J., Mortimer, P. P., And Hill, E. G., Transmission of human parvovirus B19 by coagulation factor concentrates, Vox. Sang. 58: 177–181 (1990).
Woolf, A. D., Campion, G. V., Chishick, A., Wise, S., Cohen, B. J., Klouda, P. T., Caul, O., And Dieppe, P. A., Clinical manifestations of human parvovirus B19 in adults, Arch. Intern. Med. 149: 1153–1156 (1989).
YoTO, Y., Kudoh, T., Haseyama, K., Suzuki, N., Chiba, S., And Matsunaga, Y., Human parvovirus B19 infection in Kawa-said disease [letter], Lancet 344: 58–59 (1994).
Young, N., Hematologic and hematopoietic consequences of B19 parvovirus infection, Semin. Hematol. 25: 159–172 (1988).
Young, N., Harrison, M., MooRE, J., Mortimer, P., And Humphries, R. K., Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro, J. Clin. Invest. 74: 2024–2032 (1984).
Young, N., Harrison, M., MooRE, J., Mortimer, P., And Humphries, R. K., Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro, J. Clin. Invest. 74: 2024–2032 (1984).
Anonymous, Risks associated with human parvovirus B19 infection, Morbid. Mortal. Week. Rep. 38: 81–88, 93–97 (1989).
Anderson, M. J., And Cherry, J. D., Parvoviruses, in: Textbook of Pediatric Infectious Diseases (R. D. Feigin And J. D. Cherry, Eds.), pp. 1646–1653, Saunders, Philadelphia, 1987.
Brown, K. E., Hibbs, J. R., Gallinella, G., Anderson, S. M., Lehman, E. D., Mccarthy, P., And Young, N. S., Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen), N. Engl. J. Med. 330: 1192–1196 (1994).
Brown, K. E., Young, N. S., And Liu, J. M., Molecular, cellular and clinical aspects of parvovirus B19 infection, Crit. Rev. Oncol. Hematol. 16: 1–31 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brown, K.E., Young, N.S. (1997). Parvovirus B19 Infection. In: Evans, A.S., Kaslow, R.A. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0036-4_20
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0036-4_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44856-0
Online ISBN: 978-1-4899-0036-4
eBook Packages: Springer Book Archive